Why Lenz Therapeutics Stock Plummeted by Almost 20% This Week

What: Lenz Therapeutics stock plummeted by almost **20%** this week.
Why: The stock fell due to the company's failure to meet expectations for its final quarter of **2025**.
Signal: This decline may signal a shift in investor confidence in the biotech sector.
Target: The company's stock price is now targeting a possible rebound in the second quarter of **2026**.
Risk: Investors are at risk of further losses if Lenz Therapeutics fails to recover and meet its projected growth targets.